A randomized, double-blind, placebo-and active-controlled phase iii study of tapentadol er for chronic low back pain: Analysis of efficacy endpoint sensitivity

This publication has no relations, dolmen is empty

Category Primary study
JournalThe Journal of Pain
Year 2009
Loading references information
This article has no abstract
Epistemonikos ID: 2343dee8707a75d4b345a53e0d7fa7fa224e886d
First added on: Jun 08, 2016